Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
Hoeks CM, Somford DM, van Oort IM, Vergunst H, Oddens JR, Smits GA, Roobol MJ, Bul M, Hambrock T, Witjes JA, Fütterer JJ, Hulsbergen-van de Kaa CA, Barentsz JO. Hoeks CM, et al. Among authors: somford dm. Invest Radiol. 2014 Mar;49(3):165-72. doi: 10.1097/RLI.0000000000000008. Invest Radiol. 2014. PMID: 24220253
Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O, van Melick HHE, Hooft L, Bosch JLHR, Reitsma HB, Barentsz JO, Somford DM. Wegelin O, et al. Among authors: somford dm. Eur Urol. 2017 Apr;71(4):517-531. doi: 10.1016/j.eururo.2016.07.041. Epub 2016 Aug 25. Eur Urol. 2017. PMID: 27568655 Review.
The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, Barentsz JO, Somford DM, van Melick HHE. Wegelin O, et al. Among authors: somford dm. Eur Urol. 2019 Apr;75(4):582-590. doi: 10.1016/j.eururo.2018.11.040. Epub 2018 Dec 3. Eur Urol. 2019. PMID: 30522912 Clinical Trial.
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Exterkate L, Wegelin O, Barentsz JO, van der Leest MG, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, van Melick HHE, Somford DM. Exterkate L, et al. Among authors: somford dm. Eur Urol Oncol. 2020 Apr;3(2):216-223. doi: 10.1016/j.euo.2019.06.005. Epub 2019 Jun 22. Eur Urol Oncol. 2020. PMID: 31239236
Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial.
Wegelin O, Exterkate L, van der Leest M, Kelder JC, Bosch JLHR, Barentsz JO, Somford DM, van Melick HHE. Wegelin O, et al. Among authors: somford dm. Eur Urol Oncol. 2019 Nov;2(6):617-624. doi: 10.1016/j.euo.2019.08.007. Epub 2019 Sep 11. Eur Urol Oncol. 2019. PMID: 31519516 Clinical Trial.
Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative.
Reesink DJ, van de Garde EMW, Somford DM, Meijer RP, Los M, Biesma DH, Horenblas S, van Melick HHE, van der Nat PB; Santeon MIBC Study Group. Reesink DJ, et al. Among authors: somford dm. Eur Urol Open Sci. 2021 Feb 15;26:18-26. doi: 10.1016/j.euros.2021.01.014. eCollection 2021 Apr. Eur Urol Open Sci. 2021. PMID: 34337504 Free PMC article.
105 results